JP2001501621A - 紅色酵母発酵産物を使用する方法および組成物 - Google Patents

紅色酵母発酵産物を使用する方法および組成物

Info

Publication number
JP2001501621A
JP2001501621A JP10516787A JP51678798A JP2001501621A JP 2001501621 A JP2001501621 A JP 2001501621A JP 10516787 A JP10516787 A JP 10516787A JP 51678798 A JP51678798 A JP 51678798A JP 2001501621 A JP2001501621 A JP 2001501621A
Authority
JP
Japan
Prior art keywords
red yeast
fermentation
monascus
fermentation product
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10516787A
Other languages
English (en)
Japanese (ja)
Inventor
ツァン，マオ，エル．
ポン，チー，エックス．
チャン，マイケル，エヌ．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Publication of JP2001501621A publication Critical patent/JP2001501621A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
JP10516787A 1996-09-30 1997-09-29 紅色酵母発酵産物を使用する方法および組成物 Pending JP2001501621A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72054896A 1996-09-30 1996-09-30
US08/720,548 1996-09-30
PCT/US1997/017574 WO1998014177A1 (en) 1996-09-30 1997-09-29 Methods and compositions employing red yeast fermentation products

Publications (1)

Publication Number Publication Date
JP2001501621A true JP2001501621A (ja) 2001-02-06

Family

ID=24894390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10516787A Pending JP2001501621A (ja) 1996-09-30 1997-09-29 紅色酵母発酵産物を使用する方法および組成物

Country Status (9)

Country Link
EP (1) EP0932395A1 (pt)
JP (1) JP2001501621A (pt)
KR (1) KR20000048765A (pt)
AU (1) AU4658797A (pt)
BR (1) BR9712168A (pt)
CA (1) CA2267340A1 (pt)
HU (1) HUP9904650A2 (pt)
IL (1) IL129216A0 (pt)
WO (1) WO1998014177A1 (pt)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物
JP2010260844A (ja) * 2009-04-29 2010-11-18 Sunway Biotech Co Ltd 体脂肪形成を阻害できる紅麹生成成分の組成物の製造方法
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
JP2013063925A (ja) * 2011-09-16 2013-04-11 Sunway Biotech Co Ltd 血液脂質を引き下げ、ｈｄｌコレステロールを引き上げることができる混合物とその製造方法
JP2013512913A (ja) * 2009-12-03 2013-04-18 オプヘイム ジョアル 主要心血管イベントの発生を低減させるための紅麹エキスとオメガ−３多価不飽和脂肪酸又はその誘導体とを含む物質

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436406B1 (en) 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100426880B1 (ko) * 2002-02-04 2004-04-13 학교법인 영광학원 모나스쿠스 피로수스를 이용한 적색 메주색소의 제조방법
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
ES2666459T3 (es) 2011-12-26 2018-05-04 Beijing Peking University Wbl Biotech Co., Ltd Derivado de esterol, procedimiento de preparación y finalidad del mismo
CN113171316B (zh) * 2021-04-23 2022-06-14 科丝美诗(中国)化妆品有限公司 一种修复、缓解皮肤刺激化妆品及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JP3168298B2 (ja) * 1993-02-05 2001-05-21 有限会社フジ・バイオ研究所 紅麹を使用した酒精飲料の製造法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112809A1 (ja) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. 血清尿酸低減組成物
JP2010260844A (ja) * 2009-04-29 2010-11-18 Sunway Biotech Co Ltd 体脂肪形成を阻害できる紅麹生成成分の組成物の製造方法
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
JP2013512913A (ja) * 2009-12-03 2013-04-18 オプヘイム ジョアル 主要心血管イベントの発生を低減させるための紅麹エキスとオメガ−３多価不飽和脂肪酸又はその誘導体とを含む物質
JP2013063925A (ja) * 2011-09-16 2013-04-11 Sunway Biotech Co Ltd 血液脂質を引き下げ、ｈｄｌコレステロールを引き上げることができる混合物とその製造方法

Also Published As

Publication number Publication date
AU4658797A (en) 1998-04-24
HUP9904650A2 (hu) 2000-05-28
EP0932395A1 (en) 1999-08-04
BR9712168A (pt) 2000-01-18
KR20000048765A (ko) 2000-07-25
WO1998014177A1 (en) 1998-04-09
IL129216A0 (en) 2000-02-17
CA2267340A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
EP1044009B1 (en) Methods and compositions employing red rice fermentation products
Erdoğrul et al. Review of the studies on the red yeast rice (Monascus purpureus)
KR100847104B1 (ko) 아토피 피부염 개선제 조성물
CN106798252B (zh) 一种具有调理肠胃降血脂溶血栓功效的纳豆产品
EP3351258A1 (en) Equal-containing fermentation product of soybean embryonic axis, and method for production thereof
TWI380823B (zh) 脂聯素（Ａｄｉｐｏｎｅｃｔｉｎ）濃度上升劑
KR20150110378A (ko) 후발효차 추출물을 포함하는 조성물
JP2001501621A (ja) 紅色酵母発酵産物を使用する方法および組成物
KR101729003B1 (ko) 황칠 추출물 또는 황칠액 발효대사체를 포함하는 통풍 예방 또는 치료용 조성물
KR20210098225A (ko) 감귤 발효 콤부차를 유효성분으로 포함하는 당뇨 또는 심혈관질환 치료용 조성물
KR102420930B1 (ko) 미립화된 유산균 사균체를 포함하는 비만 예방 및 치료용 조성물
KR102151373B1 (ko) 발효 노니를 포함하는 알러지 예방 및 개선용 식품 조성물 및 그 제조방법
KR20170122655A (ko) 혈관 질환 예방 및 치료용 조성물
KR101894874B1 (ko) 스트렙토마이세스 프라질리스를 이용한 항염증 조성물
KR100416650B1 (ko) 둥굴레 추출물과 그를 함유한 혈장 지질 및 혈당 강하용조성물
KR20100026600A (ko) 흑마늘 건조분말 또는 그 추출물을 유효성분으로 함유하는 지질대사 장애 및 당뇨 합병증 질환의 예방 및 치료용 조성물
WO2019131274A1 (ja) 緑茶抽出物由来の発酵物の製造方法及び緑茶抽出物由来の麹発酵物
KR101824217B1 (ko) 모로오렌지주스 및 와일드망고 종자 추출물을 포함하는 비만 또는 고지혈증 개선용 식품 조성물
KR101228554B1 (ko) 진피발효생성방법 및 이에 의한 진피발효생성물
KR20200016610A (ko) 지방간 개선제 조성물
KR100533942B1 (ko) 홍국 또는 홍국추출물을 함유한 기능성 유산균 음료의 제조방법
KR100661334B1 (ko) 항당뇨 효과를 나타내는 발효구아바 조성물
MXPA99003004A (en) Methods and compositions employing red yeast fermentation products
KR102523928B1 (ko) 바실러스 서브틸리스 낫또 배양균체 추출물을 포함하는 기억력 개선용 조성물
KR100742340B1 (ko) 혈중 콜레스테롤 수치를 개선하는 홍국균 배양조성물의제조방법.